Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSemaglutide (Wegovy) reduces appetite significantly, and for most people that is the point — but eating less also means consuming fewer vitamins and minerals. Nutritional shortfalls are a real, if often overlooked, consideration during treatment, and knowing which deficiencies to watch for helps you stay well while losing weight. Wegovy is a prescription-only medicine; a clinician assesses your individual circumstances before and during treatment, including any nutritional risks.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The decision to start weight-loss treatment is usually framed around appetite, weight and health outcomes. What gets less attention is what happens to your nutrient intake when you are consistently eating 30–40% less than before. Semaglutide slows gastric emptying and suppresses appetite through GLP-1 receptor pathways, which is well-documented in trials including the STEP 1 study published in the New England Journal of Medicine. The medicine works; and a smaller plate, eaten repeatedly over months, delivers fewer vitamins whether you plan for it or not.
This is not unique to Wegovy. Any intervention that meaningfully reduces calorie intake (bariatric surgery, very-low-calorie diets, prolonged appetite suppression) carries a nutritional dimension. The difference with GLP-1 medicines is that the reduction is gradual and the treatment period is long, so shortfalls can develop quietly before symptoms appear. People whose diets were already low in certain nutrients before starting treatment are at greater risk from the outset.
There is also a specificity worth noting: nausea, one of the most common early side effects of semaglutide, can make certain foods temporarily unappealing (dairy, red meat, eggs) which are precisely the foods richest in B12 and iron. The appetite suppression and the GI side effects can combine to narrow the diet further than intended. Understanding this helps you make a more deliberate choice about what you eat and whether you supplement.
Four nutrients attract the most attention during GLP-1 treatment, and for distinct reasons.
Vitamin B12. This vitamin is found almost exclusively in animal products, meat, fish, dairy, eggs. When those foods become less appealing or are eaten in smaller quantities, B12 intake drops. Absorption also depends on a protein called intrinsic factor in the stomach; anything that slows or reduces stomach activity can affect uptake. Deficiency develops slowly but the consequences, including fatigue, numbness or tingling in the hands and feet, and cognitive fog, are significant. The relationship between semaglutide and B12 is worth understanding in detail, particularly if you eat little red meat or follow a plant-based diet.
Vitamin D. Most UK adults have borderline-low vitamin D at some point, particularly through autumn and winter. Weight loss can affect how vitamin D is stored and mobilised in the body, since it is fat-soluble. Low mood, fatigue and muscle weakness are all associated with deficiency, and all three overlap with symptoms that patients sometimes attribute to the medicine itself. The question of vitamin D during Wegovy treatment is one our prescribers are asked regularly.
Iron. Reduced intake of red meat, lentils and fortified cereals can lower dietary iron. Women of reproductive age are already at higher statistical risk. Fatigue and reduced exercise tolerance are the most common early signs; confirmed deficiency requires a blood test rather than a symptom check alone.
Folate. Folate is found in leafy green vegetables, which some people eat less of when nausea limits their appetite for salads and raw foods. It matters for cell repair and, critically, for anyone who may become pregnant, though semaglutide is not recommended during pregnancy or for those actively trying to conceive.
This is the question most people are actually trying to answer, and it does not have a universal response. The right starting point is a blood test, ideally before you begin treatment so you have a baseline, and repeated at clinically appropriate intervals during the treatment period. The NHS guidance on semaglutide advises patients to follow their prescriber's monitoring recommendations throughout the course of treatment.
General supplementation (a standard multivitamin, a vitamin D supplement through the UK winter, and a B12 supplement for those eating little or no animal protein) is a reasonable, low-risk step for most people on long-term appetite-suppressing treatment. It is not a substitute for checking, and it is not a therapeutic dose for someone who is already deficient. A deficiency confirmed by blood test is a clinical matter requiring the right supplement form, dose and duration under medical guidance.
The vitamins most commonly considered alongside Wegovy cover several of these bases, and there is also a practical guide to choosing the right supplements if you want a more detailed breakdown. A broader overview of how semaglutide interacts with vitamin intake sets the context for any decisions you make with your prescriber.
One practical note: if you are reviewing your supplements and planning to order a repeat prescription around a bank holiday or any week when your routine shifts, plan a few days ahead. Gaps in treatment (whether from supply or from forgetting) are worth minimising during active titration.
Vitamin deficiency during Wegovy treatment is a manageable risk, not an argument against treatment. For many people, the metabolic benefits of meaningful weight loss (reduced blood pressure, improved blood sugar regulation, lower cardiovascular risk) substantially outweigh the nutritional considerations, particularly when those considerations are actively managed.
What helps most is honest, ongoing communication with your prescriber. Symptoms like persistent fatigue, low mood, tingling or hair thinning should be mentioned at your next clinical review rather than attributed automatically to the medicine. They may have a nutritional explanation that is entirely addressable.
If you are considering treatment and want to understand the clinical picture, including costs, the price context for Wegovy in the UK is worth reading alongside the clinical information. And if you are ready to discuss whether semaglutide is appropriate for you, the free consultation at nume is reviewed the same day by a GPhC-registered prescriber, a real clinician who can consider your diet, any existing deficiencies and your full health history before any decision is made.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.